The present study evaluates antihyperglycemic activity of fractionated Pycnogenol® and its ability to improve endothelial dysfunction
in diabetic animals. The aim of this study was to isolate from Pycnogenol® mixture its active compounds and compare
their efficacy on observed parameters. Pycnogenol® mixture was fractioned by re-extracting with petroleum ether, chloroform,
ethyl acetate and butanol, subsequently. Pycnogenol® mixture and fractions (butanolic, water, ethyl acetate) were administered
during 6 weeks to diabetic rats. Blood glucose levels were assessed from the arterio-venous blood at the beginning of experiment
and at the end of experiment. Endothelial dysfunction was evaluated as the contractile responses to phenylephrine and
acetylcholine. The amount of collagen I and III was assessed from thoracic aorta after picrosirius red staining. For the confirmation
of the changes on molecular level, we determinated endothelial NO synthase (eNOS) and heat shock protein 90 (Hsp90)
expression from left ventricle.
Overall, the result suggest, that fractions are not so effective on observed parameters as Pycnogenol® mixture itself, indicating
synergistic effect of the plant constituents.
If the inline PDF is not rendering correctly, you can download the PDF file here.
 Belcaro G et al. Investigation of Pycnogenol® in combination with
coenzymeQ10 in heart failure patients (NYHA II/III). Panminerva
Med. 2010;52(2 Suppl 1):21-5.
 Bozdag-Dundar O et al. Synthesis of hypoglycemic activity of
some new flavone derivatives. 4th communications: 6 flavonyl-
2,4-thiazolidinediones. Arzneimittelforschung. 2001;51:623-
 Bucala R, Tracey K., Cerami A. Advanced glycosylation products
quench nitric oxide and mediate defective endotheliumdependent
vasodilation in experimental diabetes. J Clin Invest.
 Cai H, Harrison, DG. Endothelial dysfunction in cardiovascular
diseases: the role of oxidant stress. Circ Res. 2000;87(10):840-4.
 Cesarone MR et al. Improvement of diabetic microangiopathy
with pycnogenol: A prospective, controlled study. Angiology.
 Cosentino F, Lüscher TF. Endothelial function in coronary artery
disease. Cardiologia. 1997;42(12):1221-7.
 Chang KS, Stevens WC. Endothelium-dependent increase in vascular
sensitivity to phenylephrine in long-term streptozotocin
diabetic rat aorta. Br J Pharmacol. 1992;107(4):983–990.
 Chatterjeea A, Catravas JD. Endothelial nitric oxide (NO) and
its pathophysiologic regulation. Vascular Pharmacology. 2008;
 Cheynier V et al. Size separation of condensed tannins by normal
phase high performance liquid chromatography. Methods Enzymol.
 Choudhary SK et al. Comprehensive Evaluation of Anti-hyperglycemic
Activity of Fractionated Momordica charantia Seed Extract
in Alloxan-Induced Diabetic Rats. Evid Based Complement Alternat
Med. 2012; doi:10.1155/2012/293650
 Cosentino F et al. High glucose increases nitric oxide synthase
expression and superoxide anion generation in human aortic endothelial
cells. Circulation. 1997;96:25.
 Davis BJ et al. Activation of the AMP-Activated Kinase by Antidiabetes
Drug Metformin Stimulates Nitric Oxide Synthesis In Vivo
by Promoting the Association of Heat Shock Protein 90 and Endothelial
Nitric Oxide Synthase. Diabetes. 2006;55:496-505.
 Elrod JW et al. Cardiomyocyte-Specific Overexpression of NO Synthase-
3 Protects Against Myocardial Ischemia-Reperfusion Injury.
Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:1517-
 Fitzpatrick DF et al. Endothelium dependent vascular effects
of Pycnogenol. Journal of cardiovascular pharmacology. 1998;
 Hamden K et al. Combined vitamins (C and E) and insulin improve
oxidative stress and pancreatic and hepatic injury in alloxan diabetic
rats. Biomed Pharmacother. 2009;63(2):95-9.
 Hlavačková L et al. The Effect of Indapamide on Development of
Myocardial Hypertrophy and Fibrosis in L-NAME-Induced Hypertension
in Rat. Physiol. Res. 2011;60:845-852.
 Jankyova S et al. Glucose and blood pressure lowering effects of
Pycnogenol® are inefficient to prevent prolongation of QT interval
in experimental diabetic cardiomyopathy. Pathol Res Pract.
 Jankyova S et al. Pycnogenol efficiency on glycaemia, motor
nerve conduction velocity and markers of oxidative stress in mild
type diabetes in rats. Phytother Res. 2009;23(8):1169-74.
 Jay D, Hitomi H, Griendling KK. Oxidative stress and diabetic
cardiovascular complications. Free radical Biology &Medicine.
 Kasiviswanath R, Ramesh A, Kumar KE. Hypoglycemic and antihyperglycemic
effect of Gmelina asiatica LINN. in normal and in
alloxan induced diabetic rats. Biol Pharm Bull. 2005;28(4):729-32.
 Klimas J et al. Pycnogenol improves left ventricular function in
streptozotocin-induced diabetic cardiomyopathy in rats. Phytother
 Kolacek M et al. Effect of natural polyphenols, pycnogenol® on
superoxide dismutase and nitric oxide synthase in diabetic rats.
Prague Med Rep. 2010;111(4):279-88.
 Krenek P et al. Increased expression of endothelial nitric oxide
synthase and caveolin-1 in the aorta of rats with isoproterenol-
induced cardiac hypertrophy. Can J Physiol Pharmacol.
 Lin KY et al. Impaired nitric oxide synthase pathway in diabetes
mellitus: role of asymmetric dimethylarginine and dimethylarginine
dimethylaminohydrolase. Circulation. 2002;106:987.
 Lin LY et al. Up-regulation of the association between heat shock
protein 90 and endothelial nitric oxide synthase prevents high
glucose-induced apoptosis in human endothelial cells. J Cell Biochem.
 Liu X, Zhou HJ, Rohdewald P. French Maritime Pine Bark Extract
Pycnogenol Dose-Dependently Lowers Glucose in Type 2 diabetic
Patients. Diabetes Care. 2004;27:893-896.
 Maiti R, Das UK, Ghosh D. Attenuation of hyperlycemia and hyperlipidemia
in streptozotocin induced diabetic rats by aqueous
extract of seed of Tarmarindus indica. Biol Pharm Bull.
 Maritim A, Sanders RA, Watkins JBIII. Oxidative stress and diabetic
complications: A review. J Biochem Mol Toxicol. 2003;17:24-48.
 Packer L et al. Antioxidant activity and biologic properties of a
procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol.
Free radical biology & medicine. 1999;27:704-724.
 Parveen K et al. Protective effects of Pycnogenol on hyperglycemia-
induced oxidative damage in the liver of type 2 diabetic rats.
Chem Biol Interact. 2010;186(2):219-27.
 Pieper GM et al. Reversal by L-arginine of a dysfunctional arginine/
nitric oxide pathway in the endothelium of the genetic diabetic
BB rat. Diabetologia. 1997;40:910.
 Rosei EA, Rizzoni D. Small artery remodelling in diabetes. J Cell
Mol Med. 2010;14(5):1030-6.
 Ryan EA, Pick ME, Marceau C. Use of alternative medicines in diabetes
mellitus. Diabetic Medicine. 2001;18(3):242–245.
 Schäfer A, Högger P. Oligomeric procyanidins of French maritime
pine bark extract (Pycnogenol) effectively inhibit alpha-glucosidase.
Diabetes Res Clin Pract. 2007;77(1):41-6.
 Sekar, D, Sivagnanam K, Subramanian S. Antidiabetic activity of
Momordica charantia seeds on streptozotocin induced diabetic
rats. Pharmazie. 2004;60:383–387.
 Srinivasan S et al. Hyperglycaemia-induced superoxide production
decreases eNOS expression via AP-1 activation in aortic endothelial
cells. Diabetologia. 2004;47:1727.
 Stuard S. et al. Kidney function in metabolic syndrome may be
improved with Pycnogenol®. Panminerva Med. 2010;52(2 Suppl
 Virgili F, Kim D, Packer L. Procyanidins extracted from pine bark
protect α-tocopherol in ECV 304 endothelial cells challenged by
activated RAW 264.7 macrophages: role of nitric oxide and peroxynitrite.
FEBS letters. 1998; 431(3):315-318.
 Wang Y, Marsden PA. Nitric oxide synthases: gene structure and
regulation. Adv. Pharmacol. 1995;34:71–90.
 Zibadi S et al. Reduction of cardiovascular risk factors in subjects
with type 2 diabetes by Pycnogenol supplementation. Nutrition
Research. 2008; 28(5): 315-320.